en · de · es · fr · pt
cardarine-notes.peptides9000.com › Blog › Background And Regulatory History — Deep Dive

Background And Regulatory History — Deep Dive

By Editorial Desk · published 2026-04-18 · last reviewed 2026-05-05 · Blog

This is a working overview of anti-doping, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-05-05 and is reviewed periodically as new material appears.

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Identity and Pharmacological Classification

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.

Cardarine at a glance

PropertyValueNotes
Common nameCardarineCommon internet and media name.
Research codeGW501516Also written GW-1516.
Drug classPPARδ agonistNot a selective androgen receptor modulator.
Development statusDiscontinuedClinical development halted after rodent cancer findings.
Regulatory statusProhibited in sportListed by WADA; not approved as medicine.

Cardarine as Investigational PPARδ Agonist

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

Related pages on this site

Regulation and Analytical Detection

Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.

Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.

Regulation and Detection

Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.

Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Supporting material

==== Clipper alcohol douse ==== If more than one animal is being branded the clippers must also be washed with alcohol between shaving each animal. This prevents hair particles from building up in the blades of the clippers, whose residue on the animal's skin can cause uneven or failed branding.

=== Lifestyle === Weight management and a healthy lifestyle are first-line treatments for PMOS. Weight management includes the prevention of weight gain, losing some weight, or maintaining weight loss. Limited weight loss of 5% shows metabolic benefits, and possibly benefits for reproductive health. There is little evidence that one type of healthy diet is better than another in PMOS. In terms of exercise, the general population guidance of 150 minutes of moderate-intensity exercise per week is recommended to prevent weight gain. For weight loss, 250 minutes of moderate exercise is recommended. Lifestyle changes for people with PMOS have been proven to be difficult due to various factors. Some studies indicate that women with PMOS might have problems with feeling sated after eating, making weight loss more challenging. Sleep disorders, more prevalent in women with PMOS, cause fatigue, which further makes a healthy lifestyle more difficult. Finally, issues with body image, eating disorders, depression, or lack of intrinsic motivation (not enjoying exercise) may make lifestyle interventions more difficult. Lifestyle interventions for women with PMOS may include strategies such as setting goals, tracking progress, learning assertiveness, and relapse prevention. These approaches aim to support weight control, a healthy lifestyle, and emotional well-being. Support may also involve using SMART goals (specific, measurable, achievable, realistic, and timely).

Thyrotropin-releasing hormone has a stimulatory effect on prolactin release, although prolactin is the only anterior pituitary hormone whose principal control is inhibitory. Several variants and forms are known per species. Many fish have variants prolactin A and prolactin B. Most vertebrates, including humans, also have the closely related somatolactin. In humans, 14, 16, and 22 kDa variants exist.

==== Stability ==== A disadvantage of using nanocrystals for drug delivery is nanocrystal stability. Instability problems of nanocrystalline structures derive from thermodynamic processes such as particle aggregation, amorphization, and bulk crystallization. Particles at the nanoscopic scale feature a relative excess of Gibbs free energy, due to their higher surface area to volume ratio. To reduce this excess energy, it is generally favorable for aggregation to occur. Thus, individual nanocrystals are relatively unstable by themselves and will generally aggregate. This is particularly problematic in top-down production of nanocrystals. Methods such as high-pressure homogenization and bead milling, tend to increase instabilities by increasing surface areas; to compensate, or as a response to high pressure, individual particles may aggregate or turn amorphous in structure. Such methods can also lead to the reprecipitation of the drug by surpassing the solubility beyond the saturation point (Ostwald ripening). One method to overcome aggregation and retain or increase nanocrystal stability is by use of stabilizer molecules. These molecules, which interact with the surface of the nanocrystals and prevent aggregation via ionic repulsion or steric barriers between the individual nanocrystals, include surfactants and are generally useful for stabilizing suspensions of nanocrystals. Concentrations of surfactants that are too high, however, may inhibit nanocrystal stability and enhance crystal growth or aggregation.

Sources: en.wikipedia.org

Supporting material

In the 1970s, the KGB, led by Yuri Andropov, continued to persecute distinguished Soviet dissidents, such as Aleksandr Solzhenitsyn and Andrei Sakharov, who were criticising the Soviet leadership in harsh terms. Indirect conflict between the superpowers continued through this period of détente in the Third World, particularly during political crises in the Middle East, Chile, Ethiopia, and Angola. In 1973, Nixon announced his administration was committed to seeking most favored nation trade status with the USSR, which was challenged by Congress in the Jackson-Vanik Amendment. The United States had long linked trade with the Soviet Union to its foreign policy toward the Soviet Union and, especially since the early 1980s, to Soviet human rights policies. The Jackson-Vanik Amendment, which was attached to the 1974 Trade Act, linked the granting of most-favored-nation to the USSR to the right of persecuted Soviet Jews to emigrate. Because the Soviet Union refused the right of emigration to Jewish refuseniks, the ability of the President to apply most-favored nation trade status to the Soviet Union was restricted. Although President Jimmy Carter tried to place another limit on the arms race with a SALT II agreement in 1979, his efforts were undermined by the other events that year, including the Iranian Revolution and the Nicaraguan Revolution, which both ousted pro-US governments, and his retaliation against the Soviet coup in Afghanistan in December.

Agricultural technology – or AgTech, it is the use of technology in agriculture, horticulture, and aquaculture with the aim of improving yield, efficiency, and profitability. Agricultural technology can be products, services or applications derived from agriculture that improve various input/output processes. Food science – technology in this sector focuses on the development of new functional ingredients and alternative Proteins. Foodservice – technology innovated the way establishments prepare, supply, and serve food outside the home. There's a tendency to create the conditions for the restaurant of the future with robotics and CloudKitchens. Consumer technology – technology allows what we call consumer electronics, which is the equipment of consumers with devices that facilitates the cooking process. Food delivery – as the food delivery market is growing, companies and startups are rapidly revolutionizing the communication process between consumers and food establishments, with platform-to-consumer delivery as the global lead. Supply chain – supply chain activities are considerably moving from digitization to automation.

Television broadcasting is the transmission of moving images along with a synchronized audio (sound) channel by radio. The sequence of still images is displayed on a screen on a television receiver (a "television" or TV), which includes a loudspeaker. Television (video) signals occupy a wider bandwidth than broadcast radio (audio) signals. Analog television, the original television technology, required 6 MHz, so the television frequency bands are divided into 6 MHz channels, now called "RF channels". Designations for television and FM radio broadcast frequencies vary between countries, see Television channel frequencies and FM broadcast band. Since VHF and UHF frequencies are desirable for many uses in urban areas, in North America some parts of the former television broadcasting band have been reassigned to cellular phone and various land mobile communications systems. Even within the allocation still dedicated to television, TV-band devices use channels without local broadcasters. The Apex band in the United States was a pre-WWII allocation for VHF audio broadcasting; it was made obsolete after the introduction of FM broadcasting. The current television standard, introduced beginning in 1998, is a digital format called high-definition television (HDTV), which transmits pictures at higher resolution, typically 1080 pixels high by 1920 pixels wide, at a rate of 50 or 60 interlaced fields/progressive frames per second.

pyrimidine Abbreviated in shorthand with the letter Y. A single-ringed heterocyclic organic compound which, along with purine, is one of two molecules from which all nitrogenous bases (including the nucleobases used in DNA and RNA) are derived. Cytosine (C), thymine (T), and uracil (U) are classified as pyrimidines. The letter Y is sometimes used to indicate a generic pyrimidine; e.g. in a nucleotide sequence read, Y may be used to indicate that either pyrimidine nucleobase – C, T, or U – can be substituted at the indicated position.

The structure of an ideal (infinitely long) single-walled carbon nanotube is that of a regular hexagonal lattice drawn on an infinite cylindrical surface, whose vertices are the positions of the carbon atoms. Since the length of the carbon-carbon bonds is fairly fixed, there are constraints on the diameter of the cylinder and the arrangement of the atoms on it. In the study of nanotubes, one defines a zigzag path on a graphene-like lattice as a path that turns 60 degrees, alternating left and right, after stepping through each bond. It is also conventional to define an armchair path as one that makes two left turns of 60 degrees followed by two right turns every four steps. On some carbon nanotubes, there is a closed zigzag path that goes around the tube. One says that the tube is of the zigzag type or configuration, or simply is a zigzag nanotube. If the tube is instead encircled by a closed armchair path, it is said to be of the armchair type, or an armchair nanotube. An infinite nanotube that is of one type consists entirely of closed paths of that type, connected to each other. The zigzag and armchair configurations are not the only structures that a single-walled nanotube can have. To describe the structure of a general infinitely long tube, one should imagine it being sliced open by a cut parallel to its axis, that goes through some atom A, and then unrolled flat on the plane, so that its atoms and bonds coincide with those of an imaginary graphene sheet—more precisely, with an infinitely long strip of that sheet.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Why did clinical development stop?

Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.

Is cardarine approved for medical use?

No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.

What is cardarine also known as?

Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.

Network